image_pdfimage_print

Observations from the PDAC, first two days

 

The PDAC, (or Prospectors and Developers Association of Canada, to give it its full name), is the world’s largest mining conference, and is currently taking place in Toronto, Canada.

Having attended the conference for the last eight years, I approached this conference with pessimism and little enthusiasm. Here are my observations from the first two days.

Continue reading

Colonial Coal files meeting materials and amends royalty terms

Further to their recent announcement about a business combination between Colonial Coal {TSX.V: CAD}.and Tuya Energy Inc., the respective companies have confirmed the filing the Joint Management Information Circular.

This paves the way for the respective shareholder meetings to take place for approval of the combination of the two companies.

Continue reading

Zenyatta Ventures tests show Albany Cg suitable for Lithium-ion batteries

Initial independent testing of Graphite from Zenyatta Ventures’ {TSX.V: ZEN} Albany project has yielded positive results, indicating that the graphite is “within the range of materials used in existing Lithium-Ion batteries”

This is a useful step, but the company warn that this is not confirmation of an economic deposit, as an independent feasibility study is required first.

Continue reading

Inovio Pharmaceuticals 2015 BIO CEO Investor Conference presentation

Dr. Joseph Kim, President, CEO, and director of Inovio Pharmaceuticals  {NASDAQ: INO} recently made a strong presentation to the 2015 BIO CEO Investor Conference held in the Waldorf Astoria, Park Avenue, New York City.

Dr. Kim outlined the planned developments for this year and confirmed a solid cash position of $100 million.

Continue reading

POET Technologies Announces the Completion of the 3rd Party Foundry Transfer Milestone and Corporate Updates

Toronto, ON, and Storrs, CT, February 10, 2015 – POET Technologies Inc. {TSX-V: PTK} developer of the planar opto-electronic technology (“POET”) platform for monolithic fabrication of integrated circuit devices containing both electronic and optical elements on a single semiconductor wafer – today announced the completion of its “3rd party foundry” 40/100-nm transfer milestone.

The Company also announced $4 Million in additional capital raised from institutional and accredited shareholders through the exercise of warrants during the month of January 2015, and the resignation of Dr. Adam Chowaniec from its Board.

Continue reading

Range Energy disappointed with GPK ex parte Jersey court ruling

In a continuation of one of the strangest dispute I have ever seen, after losing in the London High Court of Justice in December 2014, Gas Plus Khalakan have turned to the court system in Jersey to seek to deny Range Energy {CSE: RGO} access to data they have paid for in respect of the joint exploration licence in Iraqi Kurdistan.

This was an ex parte hearing, so Range have not yet had the right of response, and it would be hoped that when they do, the Jersey Court refers to the decision of the London High Court of Justice last year.

Continue reading

Colonial Coal benefit from Canadian interest rate cut – CEO David Austin.

Colonial Coal {TSX.V: CAD} CEO and President David Austin shared his delight as the sudden and surprise rate cut by the Canadian Central Bank.

This rate cut, with the subsequent fall in the Canadian dollar versus the US dollar is very positive for Canadian coal juniors such as Colonial” beamed a happy David Austin as the news was announced.

Continue reading

Numis lowers Condor Gold price target

Condor Gold PLC (LON:CNR) had its target price trimmed by Numis Securities Ltd from £1.00 to 90p in a research note released on Thursday morning. They currently have a buy rating on the stock.

Condor Gold plc (LON: CNR} is a London, UK based exploration company, and focuses on proving commercial reserve on its 100% owned La India Project in Nicaragua. As of December 31, 2011, La India Project had 1,620,000 ounce of gold.

Inovio Pharmaceuticals HIV Immunotherapy shows characteristics vital to Treating HIV

 

Inovio Pharmaceuticals  HIV Immunotherapy shows characteristics considered vital to Treating HIV

A small patient study confirmed that immune response characteristics within the test group generated by the immunotherapy were similar to the small group of HIV positive people whose are not progressing to the latter stages of the disease, without treatment of any kind.

Continue reading